文献速递眼底病与葡萄膜炎眼整形与眼眶

转移性结膜黑色素瘤:一项国际多中心研究

Metastatic conjunctival melanoma: a multicentre international study.
PubMed 文献 · Br J Ophthalmol · 2025-05-30

该国际多中心研究纳入10个眼科肿瘤中心的288例结膜黑色素瘤患者,29例发生转移,其中5例初诊即转移且均为AJCC cT3期伴肿瘤表面溃疡,4例在1年内死亡。随访期间24例发生转移,原发肿瘤多为cT1期。肝和肺是最常见的转移部位。

要点

  • 288例结膜黑色素瘤患者中29例发生转移,占10%。
  • 初诊即转移者均为AJCC cT3期伴表面溃疡,5例中4例1年内死亡。
  • AJCC cT类别每增加一级,转移风险升高,HR=1.89,p<0.001。

核心结论

  • 10%的结膜黑色素瘤患者发生转移性结膜黑色素瘤。
  • AJCC cT3类别、结膜位置和表面溃疡等肿瘤特异性特征与转移风险相关。
  • 初诊即转移者的生存时间较短。

研究设计与样本

  • 10个眼科肿瘤中心(来自9个国家和4个大洲)共享数据,构建大型临床病例系列。
  • 主要结局指标为全身转移的发生率和累积风险、研究死亡率及发生结膜黑色素瘤转移后的Kaplan-Meier患者死亡率。

主要发现

  • 288例患者中29例发生转移,其中5例初诊即转移,均为AJCC cT3类别并表现为肿瘤表面溃疡。
  • 初诊即转移的5例中4例(80%)为黑色素性肿瘤伴皱襞和/或泪阜受累,并在1年内死亡;1例存活21个月。
  • 随访期间24例发生转移(平均随访4.6±3.2年),其初诊原发肿瘤为cT1(13/24,54.1%)、cT2(6/24,25%)、cT3(2/24,8.3%)和3例cTx(12.5%)。
  • 研究结束时24例随访期间转移者中17例(17/24,71%)已死亡。
  • 治疗后全身转移的累积风险为1年0.4%(95%CI 0.6%至2.9%)、5年8.6%(95%CI 5.1%至14.3%)、10年22.3%(95%CI 14.5%至33.5%)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: To reveal clinical findings related to metastatic conjunctival melanoma. METHODS: 10 ophthalmic oncology centres (9 countries and 4 continents) shared data to create a large clinical case series. The main outcome measures were the incidence and cumulative risk of systemic metastasis, study mortality rates and Kaplan-Meier patient mortality after developing conjunctival melanoma metastasis. RESULTS: Of 288 patients, 29 developed metastasis. Five had metastasis at presentation, were American Joint Committee on Cancer (AJCC) cT3-category and exhibited tumour-surface ulceration. Four of five (80%) had melanotic tumours with plical and/or caruncular involvement and died within 1 year. One survived 21 months. In contrast, 24 developed metastases during follow-up (mean 4.6±3.2 years). Their primary tumours were cT1 (n=13/24, 54.1%), cT2 (n=6/24, 25%), cT3 (n=2/24, 8.3%) and 3 cTx (12.5%) at presentation. Death had occurred in 17 patients (n=17/24, 71%) by the end of the study. The cumulative risk of systemic metastasis after treatment was 0.4% (95% CI 0.6% to 2.9%) at 1 year, 8.6% (95% CI 5.1% to 14.3%) at 5 years and 22.3% (95% CI 14.5% to 33.5%) at 10 years. Each increase in AJCC cT category was associated with an 89% higher risk for metastasis (HR=1.89, p<0.001). Among all 29 patients who developed metastasis, those who presented with AJCC cT3 disease were at highest risk (p<0.001). Liver and lung (n=13 each) were the most reported metastatic sites. CONCLUSION: Metastatic conjunctival melanoma was found in 10% of conjunctival melanoma patients. Tumour-specific characteristics including AJCC cT3-category, conjunctival location and surface ulceration were associated with metastatic risk. Survival durations were shorter for those presenting with metastasis.

来源:Br J Ophthalmol,查看原文。版权归原作者所有。

引用

  1. Jain P, Finger PT, Filì M, et al. Metastatic conjunctival melanoma: a multicentre international study. Br J Ophthalmol. 2025. PMID: 39694605. doi:10.1136/bjo-2024-326043

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。